Recombinant cytokines and hematopoietic growth factors in allogeneic and autologous bone marrow transplantation.
Use of recombinant hematopoietic growth factors in the course of bone marrow transplantation has revolutionized this modality by significantly improving the safety of the procedure. It is anticipated that use of cytokines in combination and the introduction of newer agents will further reduce costs and improve antitumor responses as well.
Lazarus
H M
HM
Ireland Cancer Center, University Hospitals of Cleveland, Case Western Reserve University, OH 44106, USA.
D016026:Bone Marrow Transplantation; D002986:Clinical Trials as Topic; D016207:Cytokines / Q000627:therapeutic use*; D016298:Hematopoietic Cell Growth Factors / Q000627:therapeutic use*; D006801:Humans; D011994:Recombinant Proteins
D016207:Cytokines; D016298:Hematopoietic Cell Growth Factors; D011994:Recombinant Proteins